Siddharth Sheth, D.O., MPH
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a medical education program | $9,075 | 2 | 42.8% |
| Travel and Lodging | $5,031 | 24 | 23.7% |
| Consulting Fee | $2,159 | 1 | 10.2% |
| Honoraria | $2,025 | 1 | 9.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,650 | 1 | 7.8% |
| Food and Beverage | $1,286 | 20 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Exelixis Inc. | $13,471 | 17 | $0 (2024) |
| Coherus Biosciences Inc. | $2,286 | 4 | $0 (2024) |
| Eisai Inc. | $2,159 | 1 | $0 (2023) |
| Merck Sharp & Dohme LLC | $1,438 | 10 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $830.98 | 11 | $0 (2020) |
| AstraZeneca UK Limited | $735.09 | 1 | $0 (2019) |
| BeiGene USA, Inc. | $129.26 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $101.60 | 1 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $75.14 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,267 | 23 | Exelixis Inc. ($11,821) |
| 2023 | $2,305 | 3 | Eisai Inc. ($2,159) |
| 2022 | $9.50 | 1 | Merck Sharp & Dohme LLC ($9.50) |
| 2021 | $1,650 | 1 | Exelixis Inc. ($1,650) |
| 2020 | $1,594 | 11 | Merck Sharp & Dohme Corporation ($1,429) |
| 2019 | $1,401 | 10 | AstraZeneca UK Limited ($735.09) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/18/2024 | Exelixis Inc. | CABOMETYX (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,620.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/13/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $204.09 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/12/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $210.30 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/25/2024 | Exelixis Inc. | CABOMETYX (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,455.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/22/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $287.88 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/22/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $280.94 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/12/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $70.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/12/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $32.99 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/11/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $357.98 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/09/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $32.04 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $356.96 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/07/2024 | Coherus Biosciences Inc. | LOQTORZI (Biological) | Food and Beverage | In-kind items and services | $70.70 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $70.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/18/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $303.97 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/11/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $296.95 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/11/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $70.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/04/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: ONCOLOGY | ||||||
| 08/02/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $101.60 | General |
| Category: Oncology | ||||||
| 06/02/2024 | Coherus Biosciences Inc. | LOQTORZI (Biological) | Honoraria | Cash or cash equivalent | $2,025.00 | General |
| Category: Oncology | ||||||
| 06/02/2024 | Coherus Biosciences Inc. | LOQTORZI (Biological) | Food and Beverage | Cash or cash equivalent | $152.02 | General |
| Category: Oncology | ||||||
| 06/02/2024 | Coherus Biosciences Inc. | LOQTORZI (Biological) | Travel and Lodging | Cash or cash equivalent | $37.96 | General |
| Category: Oncology | ||||||
| 06/01/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $174.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/20/2023 | Eisai Inc. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $2,158.75 | General |
| Category: Oncology | ||||||
| 09/21/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 155 | 296 | $107,332 | $27,421 |
| 2022 | 3 | 138 | 333 | $124,102 | $33,174 |
| 2021 | 3 | 94 | 231 | $81,629 | $22,896 |
| 2020 | 6 | 174 | 338 | $116,437 | $29,395 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 67 | 144 | $56,565 | $15,092 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 58 | 122 | $33,841 | $8,356 | 24.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 30 | 30 | $16,926 | $3,974 | 23.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 52 | 162 | $63,371 | $18,091 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 47 | 132 | $36,696 | $9,705 | 26.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 39 | 39 | $24,035 | $5,378 | 22.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 35 | 100 | $38,693 | $11,361 | 29.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 37 | 109 | $29,472 | $8,325 | 28.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 22 | 22 | $13,464 | $3,210 | 23.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 31 | 92 | $28,380 | $7,695 | 27.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 32 | 115 | $30,297 | $7,264 | 24.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 32 | 32 | $18,780 | $4,320 | 23.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 26 | 44 | $15,450 | $3,816 | 24.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 22 | 22 | $13,081 | $3,553 | 27.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 31 | 33 | $10,449 | $2,747 | 26.3% |
About Siddharth Sheth, D.O., MPH
Siddharth Sheth, D.O., MPH is a Student in an Organized Health Care Education/Training Program healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2013. The National Provider Identifier (NPI) number assigned to this provider is 1982947008.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Siddharth Sheth, D.O., MPH has received a total of $21,226 in payments from pharmaceutical and medical device companies, with $14,267 received in 2024. These payments were reported across 49 transactions from 9 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a medical education program" ($9,075).
As a Medicare-enrolled provider, Sheth has provided services to 561 Medicare beneficiaries, totaling 1,198 services with total Medicare billing of $112,887. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Location Pittsburgh, PA
- Active Since 03/27/2013
- Last Updated 03/27/2013
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982947008
Products in Payments
- CABOMETYX (Drug) $13,471
- LOQTORZI (Biological) $2,286
- Lenvima (Drug) $2,159
- LENVIMA (Drug) $1,429
- IMFINZI (Drug) $830.98
- TAGRISSO (Drug) $735.09
- BRUKINSA (Drug) $129.26
- RYBREVANT (Drug) $101.60
- LIBTAYO (Biological) $75.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Pittsburgh
Liza Villaruz, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $83,935
Dr. Brandon Smith, Md, Pharmd, MD, PHARMD
Student in an Organized Health Care Education/Training Program — Payments: $72,381
Sonal Choudhary
Student in an Organized Health Care Education/Training Program — Payments: $71,395
Dr. Kevin Kang, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $48,786
Dr. Joe Tung, Md, Mba, MD, MBA
Student in an Organized Health Care Education/Training Program — Payments: $45,631
Dr. Tyler Hauer, Md Frcsc, MD FRCSC
Student in an Organized Health Care Education/Training Program — Payments: $41,677